Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

58.77
Delayed Data
As of Aug 26
 +0.01 / +0.02%
Today’s Change
56.32
Today|||52-Week Range
77.12
-14.57%
Year-to-Date
Pharmaceuticals are the New Bonds
Aug 26 / GuruFocus News - Paid Partner Content
Bristol-Myers to Reacquire Rights to Oncology Drug in Asia
Aug 15 / Zacks.com - Paid Partner Content
Merck Offers Value and Steady Dividend Growth
Aug 24 / GuruFocus News - Paid Partner Content
Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow
Aug 14 / MotleyFool.com - Paid Partner Content
Bristol-Myers Squibb Stock Will Bounce Back -- Here's How You Can Profit
Aug 22 / TheStreet.com - Paid Partner Content
3 Beaten-Up Big Pharma Stocks: Are They Bargains?
Aug 14 / MotleyFool.com - Paid Partner Content
These 3 Stocks Could Boost Their Dividends in the Next 12 Months
Aug 20 / MotleyFool.com - Paid Partner Content
Samsung biopharma unit lines up South Korea IPO
Aug 12 / FT.com - Paid Partner Content
Is It "Game Over" After Portola's FDA Rejection?
Aug 18 / MotleyFool.com - Paid Partner Content
Allergan setback prompts healthcare slide
Aug 08 / FT.com - Paid Partner Content
What Caused Arrowhead Pharmaceuticals to Skyrocket 12.5% Today
Aug 18 / MotleyFool.com - Paid Partner Content
AstraZeneca climbs to a record high
Aug 05 / FT.com - Paid Partner Content
Why Portola Pharmaceuticals Inc Is Plunging Today
Aug 18 / MotleyFool.com - Paid Partner Content
Bristol-Myers' value plunges $23bn after cancer drug fails trial
Aug 05 / FT.com - Paid Partner Content